|
RS53347B
(sr)
|
2008-12-09 |
2014-10-31 |
Gilead Sciences, Inc. |
Modulatori toll-sličnih receptora
|
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
|
EP2588455B1
(en)
|
2010-07-02 |
2018-04-04 |
Gilead Sciences, Inc. |
2-quinolinyl-acetic acid derivatives as hiv antiviral compounds
|
|
MX2012015097A
(es)
|
2010-07-02 |
2013-05-28 |
Gilead Sciences Inc |
Derivados de acido naft-2-ilacetico para tratar sida.
|
|
US8633200B2
(en)
|
2010-09-08 |
2014-01-21 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
CA2830838A1
(en)
*
|
2011-04-04 |
2012-11-10 |
Gilead Sciences, Inc. |
Process for the preparation of an hiv integrase inhibitor
|
|
EP2508511A1
(en)
|
2011-04-07 |
2012-10-10 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
EP2511273B8
(en)
|
2011-04-15 |
2019-06-26 |
Hivih |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
UA111841C2
(uk)
|
2011-04-21 |
2016-06-24 |
Гіліад Сайєнсіз, Інк. |
Сполуки бензотіазолу та їх фармацевтичне застосування
|
|
AU2012278976B2
(en)
|
2011-07-06 |
2017-05-11 |
Gilead Sciences, Inc. |
Compounds for the treatment of HIV
|
|
US8791108B2
(en)
|
2011-08-18 |
2014-07-29 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
CN102952069B
(zh)
*
|
2011-08-19 |
2014-12-17 |
中国科学技术大学 |
一种化合物及其制备方法和应用
|
|
JP2014528412A
(ja)
*
|
2011-09-30 |
2014-10-27 |
キネタ・インコーポレイテツド |
抗ウイルス化合物
|
|
WO2013062028A1
(ja)
|
2011-10-25 |
2013-05-02 |
塩野義製薬株式会社 |
Ｈｉｖ複製阻害剤
|
|
WO2013073875A1
(ko)
|
2011-11-15 |
2013-05-23 |
한국화학연구원 |
신규한 항바이러스성 피롤로피리딘 유도체 및 이의 제조방법
|
|
US9376392B2
(en)
|
2012-01-04 |
2016-06-28 |
Gilead Sciences, Inc. |
2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
|
|
US9284323B2
(en)
|
2012-01-04 |
2016-03-15 |
Gilead Sciences, Inc. |
Naphthalene acetic acid derivatives against HIV infection
|
|
US8629276B2
(en)
|
2012-02-15 |
2014-01-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
US9034882B2
(en)
|
2012-03-05 |
2015-05-19 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
US9006235B2
(en)
|
2012-03-06 |
2015-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
UY34750A
(es)
*
|
2012-04-20 |
2013-11-29 |
Gilead Sciences Inc |
?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
|
|
US8906929B2
(en)
*
|
2012-08-16 |
2014-12-09 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
EP2716639A1
(en)
|
2012-10-05 |
2014-04-09 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
EP2716632A1
(en)
|
2012-10-05 |
2014-04-09 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
EP2719685A1
(en)
|
2012-10-11 |
2014-04-16 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
TW201443037A
(zh)
|
2013-01-09 |
2014-11-16 |
Gilead Sciences Inc |
治療用化合物
|
|
US9220710B2
(en)
|
2013-01-09 |
2015-12-29 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
ES2642265T3
(es)
|
2013-01-09 |
2017-11-16 |
Gilead Sciences, Inc. |
Compuestos terapéuticos para el tratamiento de infecciones virales
|
|
TW201441197A
(zh)
*
|
2013-01-31 |
2014-11-01 |
Shionogi & Co |
Ｈｉｖ複製抑制劑
|
|
TWI694071B
(zh)
|
2013-03-01 |
2020-05-21 |
美商基利科學股份有限公司 |
治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物
|
|
WO2014164467A1
(en)
|
2013-03-13 |
2014-10-09 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
WO2014164409A1
(en)
|
2013-03-13 |
2014-10-09 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
ES2619708T3
(es)
|
2013-03-13 |
2017-06-26 |
VIIV Healthcare UK (No.5) Limited |
Inhibidores de la replicación del virus de inmunodeficiencia humana
|
|
CN105008369B
(zh)
|
2013-03-14 |
2017-07-11 |
百时美施贵宝公司 |
人类免疫缺陷病毒复制抑制剂
|
|
JP2016512558A
(ja)
*
|
2013-03-14 |
2016-04-28 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
ヒト免疫不全ウイルス複製の阻害剤
|
|
EP2821104A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
EP2821082A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Method of producing an inactivated lentivirus, especially HIV, vaccine, kit and method of use
|
|
ES2859102T3
(es)
|
2013-07-12 |
2021-10-01 |
Gilead Sciences Inc |
Compuestos de carbamoilpiridona policíclica y su uso para el tratamiento de infecciones por VIH
|
|
NO2865735T3
(https=)
|
2013-07-12 |
2018-07-21 |
|
|
|
JP6434522B2
(ja)
|
2013-09-05 |
2018-12-05 |
ダウ アグロサイエンシィズ エルエルシー |
ホウ素化アレーンを生成する方法
|
|
EP3105236B1
(en)
|
2014-02-12 |
2017-10-18 |
ViiV Healthcare UK (No.5) Limited |
Benzothiazole macrocycles as inhibitors of human immunodeficiency virus replication
|
|
US9409922B2
(en)
*
|
2014-02-18 |
2016-08-09 |
Bristol-Myers Squibb Company |
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
|
|
PT3107913T
(pt)
|
2014-02-19 |
2018-09-28 |
Viiv Healthcare Uk No 5 Ltd |
Inibidores da replicação do vírus da imunodeficiência humana
|
|
US9637501B2
(en)
|
2014-02-20 |
2017-05-02 |
Viiv Healthcare Uk (No. 5) Limited |
Pyridin-3-yl acetic acid macrocycles as inhibitors of human immunodeficiency virus replication
|
|
US9193720B2
(en)
|
2014-02-20 |
2015-11-24 |
Bristol-Myers Squibb Company |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
US10202353B2
(en)
|
2014-02-28 |
2019-02-12 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
US9975906B2
(en)
|
2014-05-16 |
2018-05-22 |
Shionogi & Co., Ltd. |
Tricyclic heterocycle derivatives having HIV replication inhibitory effect
|
|
TW201625354A
(zh)
|
2014-06-16 |
2016-07-16 |
陶氏農業科學公司 |
用於製備氧硼基化芳烴之方法
|
|
TW201613936A
(en)
|
2014-06-20 |
2016-04-16 |
Gilead Sciences Inc |
Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
|
NO2717902T3
(https=)
|
2014-06-20 |
2018-06-23 |
|
|
|
TR201807217T4
(tr)
|
2014-07-08 |
2018-06-21 |
Viiv Healthcare Uk Ltd |
Bir viral enfeksiyon sahasının tedavisinde kullanım için izoindolin türevleri.
|
|
JP6522732B2
(ja)
|
2014-07-11 |
2019-05-29 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｉｖを治療するためのトール様受容体の調節因子
|
|
EP3172189A1
(en)
*
|
2014-07-21 |
2017-05-31 |
VIIV Healthcare UK Limited |
Phenyl and tertbutylacetic acid substituted pyridinones having anti-hiv effects
|
|
US10065953B2
(en)
*
|
2014-08-27 |
2018-09-04 |
VIIV Healthcare UK (No.5) Limited |
Imidazo[1,2-A]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication
|
|
WO2016036759A1
(en)
|
2014-09-04 |
2016-03-10 |
Gilead Sciences, Inc. |
Methods of treating or preventing hiv in patients using a combination of tenofovir alafenamide and dolutegravir
|
|
SG11201701520TA
(en)
|
2014-09-16 |
2017-04-27 |
Gilead Sciences Inc |
Solid forms of a toll-like receptor modulator
|
|
TWI695003B
(zh)
|
2014-12-23 |
2020-06-01 |
美商基利科學股份有限公司 |
多環胺甲醯基吡啶酮化合物及其醫藥用途
|
|
TWI699355B
(zh)
|
2014-12-24 |
2020-07-21 |
美商基利科學股份有限公司 |
喹唑啉化合物
|
|
SG11201705192PA
(en)
|
2014-12-24 |
2017-07-28 |
Gilead Sciences Inc |
Fused pyrimidine compounds for the treatment of hiv
|
|
BR112017013440A2
(pt)
|
2014-12-24 |
2018-01-09 |
Gilead Sciences, Inc. |
compostos de isoquinolina para o tratamento de hiv
|
|
US9670205B2
(en)
|
2015-03-04 |
2017-06-06 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
KR20190057158A
(ko)
|
2015-04-02 |
2019-05-27 |
길리애드 사이언시즈, 인코포레이티드 |
폴리시클릭-카르바모일피리돈 화합물 및 그의 제약 용도
|
|
TWI700284B
(zh)
*
|
2015-05-29 |
2020-08-01 |
日商塩野義製藥股份有限公司 |
具有ｈｉｖ複製抑制作用之含氮３環性衍生物
|
|
US20180170903A1
(en)
*
|
2015-07-06 |
2018-06-21 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
RU2018102554A
(ru)
*
|
2015-07-08 |
2019-08-08 |
ВАЙВ ХЕЛТКЕР ЮКей (N5) ЛИМИТЕД |
Производные пиридин-3-ил уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека
|
|
RU2018103031A
(ru)
*
|
2015-07-09 |
2019-08-09 |
ВАЙВ ХЕЛТКЕР ЮКей (N5) ЛИМИТЕД |
Производные пиридин-3-ил уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека
|
|
US20180170904A1
(en)
|
2015-07-09 |
2018-06-21 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
KR20180035910A
(ko)
*
|
2015-08-07 |
2018-04-06 |
비브 헬스케어 유케이 (넘버5) 리미티드 |
인간 면역결핍 바이러스 복제의 억제제로서 피리딘-3-일 아세트산 유도체
|
|
WO2017025913A1
(en)
|
2015-08-10 |
2017-02-16 |
VIIV Healthcare UK (No.5) Limited |
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
|
|
TWI657086B
(zh)
|
2015-08-11 |
2019-04-21 |
英商Viiv醫療保健英國(No.5)有限公司 |
做為人類免疫缺陷病毒複製抑制劑之５－（ｎ－苯甲基四氫異喹啉－６－基）吡啶－３－基乙酸衍生物
|
|
CN108137553A
(zh)
|
2015-08-12 |
2018-06-08 |
Viiv保健英国第五有限公司 |
作为人免疫缺陷病毒复制的抑制剂的5-(n-[6,5]-稠合双环芳基四氢异喹啉-6-基)吡啶-3-基乙酸衍生物
|
|
US10214516B2
(en)
|
2015-08-12 |
2019-02-26 |
VIIV Healthcare UK (No.5) Limited |
5-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
TW201718537A
(zh)
|
2015-08-12 |
2017-06-01 |
Ｖｉｉｖ醫療保健英國（Ｎｏ．５）有限公司 |
做為人類免疫缺陷病毒複製抑制劑之吡啶－３－基乙酸衍生物
|
|
KR20180038047A
(ko)
|
2015-08-20 |
2018-04-13 |
비브 헬스케어 유케이 (넘버5) 리미티드 |
인간 면역결핍 바이러스 복제의 억제제로서 피리딘-3-일 아세트산 유도체
|
|
US20210292327A1
(en)
|
2015-08-26 |
2021-09-23 |
Gilead Sciences, Inc. |
Deuterated toll-like receptor modulators
|
|
CA2997955A1
(en)
|
2015-09-15 |
2017-03-23 |
Gilead Sciences, Inc. |
Modulators of toll-like receptors for the treatment of hiv
|
|
AU2016330895A1
(en)
|
2015-09-30 |
2018-05-10 |
Gilead Sciences, Inc. |
Compounds and combinations for the treatment of HIV
|
|
WO2017070089A1
(en)
*
|
2015-10-19 |
2017-04-27 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
SG10202004618TA
(en)
|
2015-11-19 |
2020-06-29 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
|
JP2018536001A
(ja)
|
2015-12-04 |
2018-12-06 |
ヴィーブ ヘルスケア ユーケー リミテッド |
イソインドリン誘導体
|
|
JP6732915B2
(ja)
|
2015-12-15 |
2020-07-29 |
ギリアード サイエンシーズ， インコーポレイテッド |
ヒト免疫不全ウイルス中和抗体
|
|
MA44075A
(fr)
|
2015-12-17 |
2021-05-19 |
Incyte Corp |
Dérivés de n-phényl-pyridine-2-carboxamide et leur utilisation en tant que modulateurs des interactions protéine/protéine pd-1/pd-l1
|
|
AU2016379372A1
(en)
|
2015-12-22 |
2018-08-02 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
AR108396A1
(es)
|
2016-05-06 |
2018-08-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
US10407410B2
(en)
|
2016-05-11 |
2019-09-10 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
US20190152957A1
(en)
|
2016-05-11 |
2019-05-23 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
JP2019515000A
(ja)
*
|
2016-05-11 |
2019-06-06 |
ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド |
ヒト免疫不全ウイルス複製の阻害剤としてのピリジン−３−イル酢酸誘導体
|
|
WO2017205464A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
HUE060256T2
(hu)
|
2016-06-20 |
2023-02-28 |
Incyte Corp |
Heterociklusos vegyületek mint immunmodulátorok
|
|
US10639284B2
(en)
|
2016-06-27 |
2020-05-05 |
Chemocentryx, Inc. |
Immunomodulator compounds
|
|
KR102482673B1
(ko)
|
2016-07-05 |
2022-12-30 |
광저우 맥시노벨 파마수티컬스 씨오., 엘티디. |
방향족 아세틸렌 또는 방향족 에틸렌계 화합물, 그의 중간체, 제조 방법, 약물 조성물 및 용도
|
|
EP3484866B1
(en)
|
2016-07-14 |
2022-09-07 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
CN119462611A
(zh)
|
2016-08-19 |
2025-02-18 |
吉利德科学公司 |
用于预防性或治疗性治疗hiv病毒感染的治疗性化合物
|
|
WO2018044783A1
(en)
|
2016-08-29 |
2018-03-08 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2018042332A1
(en)
|
2016-08-31 |
2018-03-08 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Combinations and uses and treatments thereof
|
|
WO2018042331A1
(en)
|
2016-08-31 |
2018-03-08 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Combinations and uses and treatments thereof
|
|
AU2017318601B2
(en)
|
2016-09-02 |
2020-09-03 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
WO2018045150A1
(en)
|
2016-09-02 |
2018-03-08 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
WO2018051250A1
(en)
|
2016-09-14 |
2018-03-22 |
Viiv Healthcare Company |
Combination comprising tenofovir alafenamide, bictegravir and 3tc
|
|
EP3519409B1
(en)
|
2016-09-28 |
2024-09-18 |
Gilead Sciences, Inc. |
Benzothiazol-6-yl acetic acid derivatives and their use for treating hiv infection
|
|
ES2881949T3
(es)
|
2016-10-27 |
2021-11-30 |
Gilead Sciences Inc |
Forma cristalina de base libre de darunavir
|
|
JP7101678B2
(ja)
|
2016-12-22 |
2022-07-15 |
インサイト・コーポレイション |
免疫調節剤としての複素環式化合物
|
|
ES2874756T3
(es)
|
2016-12-22 |
2021-11-05 |
Incyte Corp |
Derivados de triazolo[1,5-A]piridina como inmunomoduladores
|
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
US20180179202A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
LT3558990T
(lt)
|
2016-12-22 |
2022-12-27 |
Incyte Corporation |
Tetrahidroimidazo[4,5-c]piridino dariniai kaip pd-l1 internalizavimo induktoriai
|
|
EP3565810A1
(en)
|
2017-01-03 |
2019-11-13 |
ViiV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
TW201835068A
(zh)
|
2017-01-03 |
2018-10-01 |
英商Viiv醫療保健英國(No.5)有限公司 |
作為人類免疫缺乏病毒複製之抑制劑之吡啶-3-基乙酸衍生物
|
|
TW202510891A
(zh)
|
2017-01-31 |
2025-03-16 |
美商基利科學股份有限公司 |
替諾福韋埃拉酚胺(tenofovir alafenamide)之晶型
|
|
AR110922A1
(es)
|
2017-02-06 |
2019-05-15 |
Gilead Sciences Inc |
Compuestos inhibidores del vih
|
|
WO2018228984A1
(en)
*
|
2017-06-14 |
2018-12-20 |
Bayer Aktiengesellschaft |
Process for preparing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide
|
|
AR112257A1
(es)
|
2017-06-21 |
2019-10-09 |
Gilead Sciences Inc |
Anticuerpos multiespecíficos dirigidos al vih-1 gp120 y cd3 humana, composiciones que los comprende, ácido nucleico, vector y célula huésped relacionados, método para producirlos, método para detectar células que expresan gp120 y cd3, kit de anticuerpos, fragmentos de anticuerpo que se une a gp120 y método para producirlos
|
|
CN110958883A
(zh)
|
2017-06-30 |
2020-04-03 |
Viiv保健公司 |
组合及其用途和疗法
|
|
US10919852B2
(en)
|
2017-07-28 |
2021-02-16 |
Chemocentryx, Inc. |
Immunomodulator compounds
|
|
SI3661937T1
(sl)
|
2017-08-01 |
2021-11-30 |
Gilead Sciences, Inc. |
Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb
|
|
US10392405B2
(en)
|
2017-08-08 |
2019-08-27 |
Chemocentryx, Inc. |
Macrocyclic immunomodulators
|
|
TWI687415B
(zh)
|
2017-08-17 |
2020-03-11 |
美商基利科學股份有限公司 |
Hiv蛋白質膜抑制劑之固體形式
|
|
AR112412A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas de sal de colina de un inhibidor de la cápside del vih
|
|
CN111051305A
(zh)
|
2017-08-22 |
2020-04-21 |
吉利德科学公司 |
治疗性杂环化合物
|
|
JOP20180092A1
(ar)
|
2017-10-13 |
2019-04-13 |
Gilead Sciences Inc |
مثبطات hiv بروتياز
|
|
EP3700573A1
(en)
|
2017-10-24 |
2020-09-02 |
Gilead Sciences, Inc. |
Methods of treating patients co-infected with a virus and tuberculosis
|
|
WO2019123339A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
EP3728283B1
(en)
|
2017-12-20 |
2023-11-22 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
CN109988144B
(zh)
|
2017-12-29 |
2024-07-05 |
广州再极医药科技有限公司 |
芳香乙烯或芳香乙基类衍生物、其制备方法、中间体、药物组合物及应用
|
|
EP3740209A1
(en)
|
2018-01-19 |
2020-11-25 |
Gilead Sciences, Inc. |
Metabolites of bictegravir
|
|
JP7083398B2
(ja)
|
2018-02-15 |
2022-06-10 |
ギリアード サイエンシーズ， インコーポレイテッド |
ピリジン誘導体およびｈｉｖ感染を処置するためのその使用
|
|
EP3752496B1
(en)
|
2018-02-16 |
2023-07-05 |
Gilead Sciences, Inc. |
Methods and intermediates for preparing a therapeutic compound useful in the treatment of retroviridae viral infection
|
|
US10568874B2
(en)
|
2018-02-22 |
2020-02-25 |
Chemocentryx, Inc. |
Indane-amines as PD-L1 antagonists
|
|
SMT202500157T1
(it)
|
2018-03-30 |
2025-05-12 |
Incyte Corp |
Composti eterociclici come immunomodulatori
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
|
HUE061503T2
(hu)
|
2018-05-11 |
2023-07-28 |
Incyte Corp |
Tetrahidro-imidazo[4,5-C]piridin-származékok mint PD-L1 immunmodulátorok
|
|
WO2019244066A2
(en)
|
2018-06-19 |
2019-12-26 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
WO2020003093A1
(en)
|
2018-06-25 |
2020-01-02 |
VIIV Healthcare UK (No.5) Limited |
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
|
|
DK4257600T3
(da)
|
2018-07-03 |
2025-05-26 |
Gilead Sciences Inc |
Antistoffer rettet mod hiv gp120 og fremgangsmåder til at bruge dem
|
|
AU2019297362B2
(en)
|
2018-07-06 |
2022-05-26 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
|
US11186579B2
(en)
|
2018-07-06 |
2021-11-30 |
Gilead Sciences, Inc. |
Therapeutic heterocyclic compounds
|
|
KR20210033492A
(ko)
|
2018-07-16 |
2021-03-26 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv의 치료를 위한 캡시드 억제제
|
|
TWI829205B
(zh)
|
2018-07-30 |
2024-01-11 |
美商基利科學股份有限公司 |
抗hiv化合物
|
|
JP7313438B2
(ja)
|
2018-09-19 |
2023-07-24 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｉｖの予防のためのインテグラーゼ阻害剤
|
|
EP3860717A1
(en)
|
2018-10-03 |
2021-08-11 |
Gilead Sciences, Inc. |
Imidozopyrimidine derivatives
|
|
WO2020092528A1
(en)
|
2018-10-31 |
2020-05-07 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
|
|
US11203591B2
(en)
|
2018-10-31 |
2021-12-21 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds
|
|
WO2020176505A1
(en)
|
2019-02-25 |
2020-09-03 |
Gilead Sciences, Inc. |
Protein kinase c agonists
|
|
WO2020176510A1
(en)
|
2019-02-25 |
2020-09-03 |
Gilead Sciences, Inc. |
Protein kinase c agonists
|
|
EP3934757B1
(en)
|
2019-03-07 |
2023-02-22 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
2'3'-cyclic dinucleotides and prodrugs thereof
|
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
WO2020178770A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
|
MY201239A
(en)
|
2019-03-22 |
2024-02-13 |
Gilead Sciences Inc |
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
|
|
TW202104210A
(zh)
|
2019-04-17 |
2021-02-01 |
美商基利科學股份有限公司 |
Hiv蛋白酶抑制劑
|
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI751516B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
US20200347036A1
(en)
|
2019-04-17 |
2020-11-05 |
Gilead Sciences, Inc. |
Solid forms of an hiv protease inhibitor
|
|
TW202231277A
(zh)
|
2019-05-21 |
2022-08-16 |
美商基利科學股份有限公司 |
鑑別對使用gp120 v3聚醣導向之抗體的治療敏感之hiv病患的方法
|
|
TWI810456B
(zh)
|
2019-05-22 |
2023-08-01 |
美商基利科學股份有限公司 |
Tlr7調節化合物及hiv疫苗之組合
|
|
EP3972695A1
(en)
|
2019-05-23 |
2022-03-30 |
Gilead Sciences, Inc. |
Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
|
|
RU2717101C1
(ru)
|
2019-06-03 |
2020-03-18 |
Андрей Александрович Иващенко |
Анелированные 9-гидрокси-1,8-диоксо-1,3,4,8-тетрагидро-2Н-пиридо[1,2-a]пиразин-7-карбоксамиды - ингибиторы интегразы ВИЧ, способы их получения и применения
|
|
CA3140708A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
WO2020263830A1
(en)
|
2019-06-25 |
2020-12-30 |
Gilead Sciences, Inc. |
Flt3l-fc fusion proteins and methods of use
|
|
BR112021025888A2
(pt)
|
2019-07-10 |
2022-04-26 |
Chemocentryx Inc |
Indanos como inibidores de pd-l1
|
|
KR20240137107A
(ko)
|
2019-07-16 |
2024-09-19 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 백신, 및 이의 제조 및 사용 방법
|
|
US20220257619A1
(en)
|
2019-07-18 |
2022-08-18 |
Gilead Sciences, Inc. |
Long-acting formulations of tenofovir alafenamide
|
|
JP7665593B2
(ja)
|
2019-08-09 |
2025-04-21 |
インサイト・コーポレイション |
Ｐｄ－１／ｐｄ－ｌ１阻害剤の塩
|
|
WO2021034804A1
(en)
|
2019-08-19 |
2021-02-25 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
|
PE20221038A1
(es)
|
2019-09-30 |
2022-06-17 |
Incyte Corp |
Compuestos de pirido[3,2-d] pirimidina como inmunomoduladores
|
|
CA3160131A1
(en)
|
2019-11-11 |
2021-05-20 |
Incyte Corporation |
Salts and crystalline forms of a pd-1/pd-l1 inhibitor
|
|
CA3157275C
(en)
|
2019-11-26 |
2026-02-10 |
Gilead Sciences, Inc. |
Capsid inhibitors for the prevention of hiv
|
|
IL294032A
(en)
|
2019-12-24 |
2022-08-01 |
Carna Biosciences Inc |
Compounds that regulate diacylglycerol kinase
|
|
PE20221569A1
(es)
|
2020-02-24 |
2022-10-06 |
Gilead Sciences Inc |
Compuestos tetraciclicos para el tratamiento de infecciones por vih
|
|
WO2021188959A1
(en)
|
2020-03-20 |
2021-09-23 |
Gilead Sciences, Inc. |
Prodrugs of 4'-c-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
|
|
EP4153181A1
(en)
|
2020-05-21 |
2023-03-29 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising bictegravir
|
|
TWI858267B
(zh)
|
2020-06-25 |
2024-10-11 |
美商基利科學股份有限公司 |
用於治療hiv之蛋白殼抑制劑
|
|
EP4192474B1
(en)
|
2020-08-07 |
2025-09-10 |
Gilead Sciences, Inc. |
Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use
|
|
ES3064867T3
(en)
|
2020-09-30 |
2026-04-29 |
Gilead Sciences Inc |
Bridged tricyclic carbamoylpyridone compounds for a use in the treatment of hiv
|
|
TW202406932A
(zh)
|
2020-10-22 |
2024-02-16 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
|
WO2022099018A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Process of preparing a pd-1/pd-l1 inhibitor
|
|
CR20230230A
(es)
|
2020-11-06 |
2023-07-27 |
Incyte Corp |
Proceso para hacer un inhibidor de pd-1/pdl1 y sales y formas cristalinas del mismo
|
|
TW202233615A
(zh)
|
2020-11-06 |
2022-09-01 |
美商英塞特公司 |
Ｐｄ—１／ｐｄ—ｌ１抑制劑之結晶形式
|
|
PL4244396T3
(pl)
|
2020-11-11 |
2025-12-22 |
Gilead Sciences, Inc. |
Sposoby identyfikacji pacjentów z hiv wrażliwych na terapię przeciwciałami skierowanymi na miejsce wiązania cd4 gp120
|
|
US11613546B2
(en)
|
2021-01-19 |
2023-03-28 |
Gilead Sciences, Inc. |
Substituted pyridotriazine compounds and uses thereof
|
|
WO2022245671A1
(en)
|
2021-05-18 |
2022-11-24 |
Gilead Sciences, Inc. |
Methods of using flt3l-fc fusion proteins
|
|
MX2023014762A
(es)
|
2021-06-23 |
2024-01-15 |
Gilead Sciences Inc |
Compuestos moduladores de diacilglicerol quinasa.
|
|
JP7651018B2
(ja)
|
2021-06-23 |
2025-03-25 |
ギリアード サイエンシーズ， インコーポレイテッド |
ジアシルグリセロールキナーゼ調節化合物
|
|
JP7686091B2
(ja)
|
2021-06-23 |
2025-05-30 |
ギリアード サイエンシーズ， インコーポレイテッド |
ジアシルグリセロールキナーゼ調節化合物
|
|
AU2022299051B2
(en)
|
2021-06-23 |
2025-03-13 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
MX2024003795A
(es)
*
|
2021-09-29 |
2024-06-03 |
Repare Therapeutics Inc |
Compuestos de n-(5-sustituido-[(1,3,4-tiadiazolil) o (tiazolil)])(sustituido)carboxamida y uso de estos para inhibir la polimerasa theta humana.
|
|
CR20240223A
(es)
|
2021-12-03 |
2024-07-08 |
Gilead Sciences Inc |
Compuestos terapéuticos para la infección por el virus del vih
|
|
US12084467B2
(en)
|
2021-12-03 |
2024-09-10 |
Gilead Sciences, Inc. |
Therapeutic compounds for HIV virus infection
|
|
US12404262B2
(en)
|
2021-12-03 |
2025-09-02 |
Gilead Sciences, Inc. |
Therapeutic compounds for HIV virus infection
|
|
TW202446773A
(zh)
|
2022-04-06 |
2024-12-01 |
美商基利科學股份有限公司 |
橋聯三環胺甲醯基吡啶酮化合物及其用途
|
|
TWI867601B
(zh)
|
2022-07-01 |
2024-12-21 |
美商基利科學股份有限公司 |
可用於ｈｉｖ病毒感染之疾病預防性或治療性治療的治療性化合物
|
|
CA3259040A1
(en)
|
2022-07-12 |
2024-01-18 |
Gilead Sciences, Inc. |
HIV Immunogenic Polypeptides and Vaccines and Their Uses
|
|
AU2023330037A1
(en)
|
2022-08-26 |
2025-03-06 |
Gilead Sciences, Inc. |
Dosing and scheduling regimen for broadly neutralizing antibodies
|
|
AU2023352129A1
(en)
*
|
2022-09-29 |
2025-05-01 |
Repare Therapeutics Inc. |
N-(5-substituted-[(1,3,4-thiadiazolyl) or (1,3-thiazolyl)](substituted)carboxamide compounds, pharmaceutical compositions, and methods of preparing the amide compounds and of their use
|
|
US20240226130A1
(en)
|
2022-10-04 |
2024-07-11 |
Gilead Sciences, Inc. |
4'-thionucleoside analogues and their pharmaceutical use
|
|
US20240390349A1
(en)
|
2023-04-19 |
2024-11-28 |
Gilead Sciences, Inc. |
Dosing regimen of capsid inhibitor
|
|
US20250042926A1
(en)
|
2023-05-31 |
2025-02-06 |
Gilead Sciences, Inc. |
Therapeutic compounds for hiv
|
|
US20250051375A1
(en)
|
2023-05-31 |
2025-02-13 |
Gilead Sciences, Inc. |
Anti-hiv compounds
|
|
CN121219281A
(zh)
|
2023-05-31 |
2025-12-26 |
吉利德科学公司 |
用于治疗hiv的化合物的固体形式
|
|
WO2025029247A1
(en)
|
2023-07-28 |
2025-02-06 |
Gilead Sciences, Inc. |
Weekly regimen of lenacapavir for the treatment and prevention of hiv
|
|
WO2025042394A1
(en)
|
2023-08-23 |
2025-02-27 |
Gilead Sciences, Inc. |
Dosing regimen of hiv capsid inhibitor
|
|
WO2025076542A1
(en)
|
2023-10-05 |
2025-04-10 |
Jones R Brad |
Atovaquone as an ros inducer for use in the elimination of hiv-infected t-cells
|
|
US20250122219A1
(en)
|
2023-10-11 |
2025-04-17 |
Gilead Sciences, Inc. |
Bridged tricyclic carbamoylpyridone compounds and uses thereof
|
|
TW202515549A
(zh)
|
2023-10-11 |
2025-04-16 |
美商基利科學股份有限公司 |
橋聯三環胺甲醯基吡啶酮化合物及其用途
|
|
US20250127801A1
(en)
|
2023-10-11 |
2025-04-24 |
Gilead Sciences, Inc. |
Bridged tricyclic carbamoylpyridone compounds and uses thereof
|
|
US20250230163A1
(en)
|
2023-12-22 |
2025-07-17 |
Gilead Sciences, Inc. |
Solid forms of hiv integrase inhibitors
|
|
US20250333424A1
(en)
|
2024-03-01 |
2025-10-30 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
WO2025184452A1
(en)
|
2024-03-01 |
2025-09-04 |
Gilead Sciences, Inc. |
Solid forms of hiv integrase inhibitors
|
|
US20250296932A1
(en)
|
2024-03-01 |
2025-09-25 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising hiv integrase inhibitors
|
|
WO2025212814A1
(en)
|
2024-04-03 |
2025-10-09 |
Gilead Sciences, Inc. |
Anti-hiv compounds
|
|
US20260007683A1
(en)
|
2024-06-14 |
2026-01-08 |
Gilead Sciences, Inc. |
Pharmaceutical compositions comprising hiv integrase inhibitors
|
|
WO2026038155A1
(en)
*
|
2024-08-16 |
2026-02-19 |
Pfizer Inc. |
Substituted pyridine compounds
|
|
WO2026076265A1
(en)
|
2024-10-03 |
2026-04-09 |
Gilead Sciences, Inc. |
Combination therapy comprising bridged tricyclic carbamoylpyridone compounds and p-glycoprotein inhibitors
|